Ajani UA, Ford ES, Mokdad AH (2004). Prevalence of high C-reactive protein in persons with serum lipid concentrations within recommended values. Clinical Chemistry 50, 1618–1622.
Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker L (2007). The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychological Medicine 37, 1775–1786.
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research 52, 69–77.
Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ (2008). Inflammatory markers in late-life depression: results from a population-based study. Journal of Affective Disorders 106, 249–255.
Broadley AJ, Korszun A, Jones CJ, Frenneaux MP (2002). Arterial endothelial function is impaired in treated depression. Heart 88, 521–523.
Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001). Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26, 797–808.
Danner M, Kasl SV, Abramson JL, Vaccarino V (2003). Association between depression and elevated C-reactive protein. Psychosomatic Medicine 65, 347–356.
De BD, Campanella D, Gambi F, La RR, Carano A, Conti CM, Sivestrini C, Serroni N, Piersanti D, Di GB, Moschetta FS, Cotellessa C, Fulcheri M, Salerno RM, Ferro FM (2006). The role of C-reactive protein in mood disorders. International Journal of Immunopathology and Pharmacology 19, 721–725.
Elovainio M, Keltikangas-Jarvinen L, Pulkki-Raback L, Kivimaki M, Puttonen S, Viikari L, Rasanen L, Mansikkaniemi K, Viikari J, Raitakari OT (2006). Depressive symptoms and C-reactive protein: the Cardiovascular Risk in Young Finns Study. Psychological Medicine 36, 797–805.
Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P (2005). Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 111, 2299–2305.
Ford DE, Erlinger TP (2004). Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 164, 1010–1014.
Gimeno D, Kivimaki M, Brunner EJ, Elovainio M, De VR, Steptoe A, Kumari M, Lowe GD, Rumley A, Marmot MG, Ferrie JE (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychological Medicine 39, 413–423.
Hestad KA, Aukrust P, Tonseth S, Reitan SK (2009). Depression has a strong relationship to alterations in the immune, endocrine and neural system. Current Psychiatry Reviews 5, 287–297.
Holmen J, Midthjell K, Kruger Ø, Langhammer A, Holmen TL, Bratberg GH, Vatten L, Lund-Larsen PG (2003). The Nord-Trøndelag Health Study 1995–97 (HUNT 2): Objectives, content, methods and participation. Norsk Epidemiologi 13, 19–32.
Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71, 171–186.
Kiecolt-Glaser JK, Glaser R (2002). Depression and immune function: central pathways to morbidity and mortality. Journal of Psychosomatic Research 53, 873–876.
Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S, Ishiguro N (2009). Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis and Rheumatism 61, 1018–1024.
Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F (2005). Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurology 4, 371–380.
Lawlor DA, Smith GD, Rumley A, Lowe GD, Ebrahim S (2005). Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study. Thrombosis and Haemostasis 93, 955–963.
Lesperance F, Frasure-Smith N, Theroux P, Irwin M (2004). The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. American Journal of Psychiatry 161, 271–277.
Lestage J, Verrier D, Palin K, Dantzer R (2002). The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain, Behavior, and Immunity 16, 596–601.
Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Meyer-Rochow VB, Timonen M (2006). The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 60, 825–830.
McCaffery JM, Frasure-Smith N, Dube MP, Theroux P, Rouleau GA, Duan Q, Lesperance F (2006). Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosomatic Medicine 68, 187–200.
Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA (2003). Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain, Behavior, and Immunity 17, 276–285.
Miller GE, Freedland KE, Duntley S, Carney RM (2005). Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. American Journal of Cardiology 95, 317–321.
Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ (2004). Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. Journal of Clinical Epidemiology. 57, 1096–1103.
Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24–31.
Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B (2001). Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. American Journal of Cardiology. 88, 196–198, A7.
Ridker PM, Buring JE, Cook NR, Rifai N (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107, 391–397.
Rodriguez-Moran M, Guerrero-Romero F (1999). Increased levels of C-reactive protein in non-controlled type II diabetic subjects. Journal of Diabetes and Its Complications 13, 211–215.
Serebruany VL, Glassman AH, Malinin AI, Sane DC, Finkel MS, Krishnan RR, Atar D, Lekht V, O'Connor CM (2003). Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagulation and Fibrinolysis 14, 563–567.
Skala JA, Freedland KE, Carney RM (2006). Coronary heart disease and depression: a review of recent mechanistic research. Canadian Journal of Psychiatry 51, 738–745.
Snaith RP, Zigmond AS (1986). The hospital anxiety and depression scale. British Medical Journal (Clinical Research Edition) 292, 344.
Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MM (2003). Inflammatory proteins and depression in the elderly. Epidemiology 14, 103–107.
Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S (2007). Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biological Psychiatry 62, 314–320.